Subdermal Contraceptive Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030

Subdermal Contraceptive Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030

Subdermal Contraceptive Implants Market By Type (Etonogestrel Implant And Levonorgestrel Implant), Type Of Implant (Single Rod Implant And Double Rod Implant), End-User (Hospitals, Gynecology Clinics, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing increasing number of unwanted pregnancies and rising government initiatives raising awareness regarding sexual health and family planning

The global subdermal contraceptive implants market is estimated to grow at a CAGR of 3.57% during the forecast period from 2024 to 2030. The demand for subdermal contraceptive implants is primarily being boosted by the increasing number of unwanted pregnancies. Additionally, rising government initiatives raising awareness regarding sexual health and family planning is another key factor influencing the demand for the subdermal contraceptive implants market during the forecast period from 2024-2030.

Subdermal Contraceptive Implants Market Dynamics:

According to the United Nations Population Fund 2022, nearly half of all pregnancies, which accounts for 121 million pregnancies each year on average are unintended, globally. The same source further stated that globally, an estimated 257 million women who want to avoid pregnancy are not using safe or modern methods of contraception.

Additionally, as per the Office for Health Improvement & Disparities (Government of United Kingdom) 2024, it was stated that 214,869 abortions were reported in England and Wales in 2021, which stands as the highest figure on record since the commencement of data collection.

Subdermal contraceptive implants are highly effective at preventing pregnancy, with very low failure rates. This makes them appealing to individuals who want a reliable form of contraception to avoid unintended pregnancies.

Therefore, rising incidence of unwanted pregnancies, will eventually help to propel the market subdermal contraceptive implants during the forecast years.

Another driver for the subdermal contraceptive implants market is rising government initiatives raising awareness regarding sexual health and family planning. Many countries have integrated comprehensive sexuality education into school curriculums. These programs provide young people with accurate information about sexual and reproductive health, including contraception, and STI prevention. Additionally, several governments have established national family planning programs aimed at providing access to contraception and reproductive health services. For instance, in 1952, India was the first country in the world to have launched a National Programme for Family Planning. Government initiatives aimed at promoting family planning often include education campaigns about different contraceptive options, including subdermal contraceptives. By raising awareness about the benefits and availability of subdermal contraceptives, these initiatives can increase demand for these products among individuals seeking effective birth control methods. Thus, the aforementioned factors will eventually drive the subdermal contraceptive market during the forecast period.

However, the availability of alternative contraceptive methods and side effects associated with the subdermal contraceptive implants may limit the growth of the Subdermal Contraceptive Implants market.

Subdermal Contraceptive Implants Market Segment Analysis:

Subdermal contraceptive implants market by Type (Etonogestrel Implant and Levonorgestrel Implant), Type of Implant (Single rod implant and Double rod implant), End-User (Hospitals, Gynecology Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the subdermal contraceptive implants market, the levonorgestrel category is estimated to amass a significant revenue share in the subdermal contraceptive Implants market in 2023. This can be attributed to the various advantages provided by the category over other alternative products.

Levonorgestrel implants provide highly effective contraception for an extended period, typically ranging from three to five years. Once inserted, they continuously release a low dose of levonorgestrel, ensuring consistent protection against pregnancy without the need for daily or frequent administration. Additionally, once the levonorgestrel implant is inserted, it require minimal ongoing maintenance or user involvement. This convenience can enhance user satisfaction and adherence to contraception, reducing the risk of unintended pregnancy. Further, levonorgestrel implants are reversible forms of contraception. They can be removed at any time by a healthcare provider, allowing individuals to regain fertility quickly if they wish to conceive.

Therefore, owing to the above-mentioned factors, the levonorgestrel category is expected to register significant growth, thereby driving the growth of the overall growth of the subdermal contraceptive implants market during the forecast period.

North America Is Expected To Dominate The Overall Subdermal Contraceptive Implants Market:

North America is expected to account for the highest proportion of the Subdermal Contraceptive Implants Market in 2023, out of all regions. This is due to the increasing incidence of unintended pregnancies in the region. Additionally, the presence of robust research and development initiatives, and a highly viable market in product development and launches are some of the key factors driving the growth of the Subdermal Contraceptive Implants market in North America.

As per the Office of Disease Prevention and Health Promotion (2021), in 2020, almost half (45%) of the 6.1 million annual pregnancies in the United States were found to be unintended. An increase in unintended pregnancies would also lead to a rise in the need for reliable contraceptives, thereby causing an increase in the overall market growth of the subdermal contraceptive implants market.

Further, the presence of various subdermal contraceptive implants in the research & developmental phase will create significant possibilities to drive the market for subdermal contraceptive implants. For instance, in April 2022, ProMed Pharma began preclinical evaluation of a novel, fully resorbable contraceptive implant after getting the funds from the Bill & Melinda Gates Foundation.

Therefore, according to the factors mentioned above, the North American market for subdermal contraceptive implants will grow, and will eventually drive the overall subdermal contraceptive market during the forecast period.

Subdermal Contraceptive Implants Market Key Players:

Some of the key market players operating in the subdermal contraceptive implants market include Bayer AG, Merck & Co., Inc., Shanghai Dahua Pharmaceutical Co., Ltd., Organon group of companies, and others.

Recent Developmental Activities In The Subdermal Contraceptive Implants Market:

In February 2023, the Family Planning Association of India (FPAI) was actively promoting the adoption of Implanon NXT, a novel contraceptive method.

Key Takeaways From The Subdermal Contraceptive Implants Market Report Study

Market size analysis for current subdermal contraceptive implants market size (2023), and market forecast for 6 years (2024-2030)

Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global subdermal contraceptive implants market.

Various opportunities available for the other competitors in the subdermal contraceptive implants market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current subdermal contraceptive implants market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Subdermal Contraceptive Implants market growth in the coming future?

Target Audience Who Can Be Benefited From This Subdermal Contraceptive Implants Market Report Study

Subdermal Contraceptive Implant product providers

Research organizations and consulting companies

Subdermal Contraceptive Implants related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in subdermal contraceptive implants

Various end-users who want to know more about the subdermal contraceptive implants market and the latest technological developments in the subdermal contraceptive implants market.

Frequently Asked Questions For The Subdermal Contraceptive Implants Market:

1. What are Subdermal Contraceptive Implants?

Subdermal contraceptive implants are small, flexible rods or tubes that are inserted beneath the skin of the upper arm to provide long-term contraception. These implants release a progestin hormone gradually over time, which prevents pregnancy by thickening cervical mucus, thinning the lining of the uterus, and inhibiting ovulation.

2. What is the market for Subdermal Contraceptive Implants?

The global subdermal contraceptive implants market is estimated to grow at a CAGR of 3.57% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Subdermal Contraceptive Implants market?

The Subdermal Contraceptive Implants Market is slated to witness prosperity owing to the increasing number of unwanted pregnancies. Additionally, rising government initiatives raising awareness regarding sexual health and family planning is another key factor influencing the demand for subdermal contraceptive implants market during the forecast period from 2024-2030.

4. Who are the key players operating in the global Subdermal Contraceptive Implants market?

Some of the key market players operating in subdermal contraceptive implants include Bayer AG, Merck & Co., Inc., Shanghai Dahua Pharmaceutical Co., Ltd., Organon Group of companies, and others.

5. Which region has the highest share in the global Subdermal Contraceptive Implants market?

North America is expected to dominate the overall subdermal contraceptive implants market during the forecast period from 2024 to 2030. This is due to the increasing incidence of unintended pregnancies in the region. Additionally, presence of robust research and development initiatives, and a highly viable market in terms of product development, and launches are some of the key factors driving the growth of the subdermal contraceptive implants market in North America.